Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy

Programmed death protein 1 (PD-1) interaction with PD-L1 deliver immunosuppressive environment for tumor growth, and its blockade with directed monoclonal antibodies (anti-PD-1/anti-PD-L1) has shown remarkable clinical outcome. Lately, their soluble counterparts, sPD-1 and sPD-L1, have been detected...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad, Zhao, Zhihong, Arooj, Sumbal, Fu, Yuxiang, Liao, Guixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710690/
https://www.ncbi.nlm.nih.gov/pubmed/33329567
http://dx.doi.org/10.3389/fimmu.2020.587460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710690/
https://www.ncbi.nlm.nih.gov/pubmed/33329567
http://dx.doi.org/10.3389/fimmu.2020.587460

Ejemplares similares